BOLD

Boundless Bio (BOLD)

Boundless Bio Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BOLD

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 13 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2017/06/28	21:00	PR Newswire (US)	Audentes Therapeutics Announces Participation in Upcoming Investor Conferences	NASDAQ:BOLD	Boundless Bio Inc
2017/06/14	06:25	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BOLD	Boundless Bio Inc
2017/06/14	06:24	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:BOLD	Boundless Bio Inc
2017/06/14	05:32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BOLD	Boundless Bio Inc
2017/06/08	05:31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BOLD	Boundless Bio Inc
2017/06/02	05:33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BOLD	Boundless Bio Inc
2017/05/12	05:19	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BOLD	Boundless Bio Inc
2017/05/11	21:16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BOLD	Boundless Bio Inc
2017/05/10	21:00	PR Newswire (US)	Audentes Therapeutics to Present At Upcoming Investor Conferences	NASDAQ:BOLD	Boundless Bio Inc
2017/05/08	21:00	PR Newswire (US)	Audentes Therapeutics Announces Appointment of John T. Gray, Ph.D. to Senior Vice President and Chief Scientific Officer	NASDAQ:BOLD	Boundless Bio Inc
2017/05/06	05:32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BOLD	Boundless Bio Inc
2017/05/03	21:00	PR Newswire (US)	Audentes Therapeutics Announces Presentation of Data at the American Society of Gene and Cell Therapy Annual Meeting	NASDAQ:BOLD	Boundless Bio Inc
2017/04/28	05:53	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:BOLD	Boundless Bio Inc
2017/04/28	05:31	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:BOLD	Boundless Bio Inc
2017/04/28	05:17	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:BOLD	Boundless Bio Inc
2017/04/26	19:05	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BOLD	Boundless Bio Inc
2017/04/20	05:10	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	NASDAQ:BOLD	Boundless Bio Inc
2017/04/19	19:01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:BOLD	Boundless Bio Inc
2017/04/19	07:44	PR Newswire (US)	Audentes Therapeutics Announces Pricing of Public Offering of Common Stock	NASDAQ:BOLD	Boundless Bio Inc
2017/04/19	07:09	Edgar (US Regulatory)	Registration of Additional Securities (up to 20%) (s-1mef)	NASDAQ:BOLD	Boundless Bio Inc
2017/04/18	05:03	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:BOLD	Boundless Bio Inc
2017/04/18	05:01	PR Newswire (US)	Audentes Therapeutics Announces Proposed Public Offering of Common Stock	NASDAQ:BOLD	Boundless Bio Inc
2017/04/17	21:00	PR Newswire (US)	Audentes Therapeutics to Present at the ARM 5th Annual Cell & Gene Therapy Investor Day	NASDAQ:BOLD	Boundless Bio Inc
2017/04/12	05:17	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:BOLD	Boundless Bio Inc
2017/04/10	20:19	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:BOLD	Boundless Bio Inc
2017/04/04	06:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BOLD	Boundless Bio Inc
2017/04/03	21:00	PR Newswire (US)	Audentes Therapeutics Announces FDA Clearance of Investigational New Drug Application for AT132 to Treat X-Linked Myotubular ...	NASDAQ:BOLD	Boundless Bio Inc
2017/03/24	02:43	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:BOLD	Boundless Bio Inc
2017/03/20	21:00	PR Newswire (US)	Audentes Therapeutics Announces Presentation Of Data From RECENSUS, A Medical Chart Review Of Patients With X-Linked Myotubul...	NASDAQ:BOLD	Boundless Bio Inc
2017/03/13	19:05	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:BOLD	Boundless Bio Inc